- Poster presentation
- Published:
What effect of vasoactive drugs on passive leg raising response in critically ill patients?
Critical Care volume 9, Article number: P51 (2005)
Introduction
Passive leg raising (PLR) mimics the hemodynamic effects of rapid fluid loading (FL) by shifting venous blood from the legs towards the intrathoracic compartment and by increasing right and left ventricular preloads.
Aim
To test the effect of vasoactive drugs on PLR response.
Patients and methods
During a period of 2 months (September–November 2004) were enrolled all patients with sepsis or septic shock under mechanical ventilation who needed FL. The hemodynamic measures include heart rate, invasive arterial pressure, pulse pressure (PP), venous central pressure in a supine position and after leg raising (45°); before and immediately after FL of 300 ml saline solution.
Results
Twenty-eight hemodynamics measures were made. All patients were mechanically ventilated and deeply sedated. Age 55 ± 18 years, SAPS II 37 ± 17. The patients were divided into two groups.
Group 1 (with vasoactive drug): nine measures, age 58 ± 15 years, SAPS II 48 ± 26. The increase of PP after PLR is 4 ± 2.7 mmHg, while the increase of PP after FL is 5 ± 3 mmHg.
Group 2 (without vasoactive drug): 19 measures, age 54 ± 19 years, SAPS II 33 ± 10. The increase of arterial PP after PLR is 10 ± 8 mmHg while the increase of PP after FL is 8.3 ± 7 mmHg.
Discussion
PLR predicts the effect of FL in all patients. It depends in part on the volume of blood contained in the leg vessels. The PP increase after PLR is more important in patients without vasoactive drugs (10 ± 8 vs 4 ± 2.7 mmHg).
Conclusion
PLR is a very simple technique to predict the effect of FL. Its effects seem to be less important in patients with vasoactive drugs.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Alaya, S., Abdellatif, S., Ksouri, H. et al. What effect of vasoactive drugs on passive leg raising response in critically ill patients?. Crit Care 9 (Suppl 1), P51 (2005). https://doi.org/10.1186/cc3114
Published:
DOI: https://doi.org/10.1186/cc3114